The regulations of medical and recreational cannabis are constantly changing in recent
years, both in United States and in many other countries around the world [
[1]
]. As a consequence of the changing laws and public opinion, the prevalence of cannabis
use is in a steady rise, both in adolescents and young adults, and in older adults
[
2
,
3
,
4
,
5
]. The potency of recreational cannabis is also on the rise, reflected by increase
in the concentration of Δ9-tetrahydrocannabinol (Δ9-THC) and increase in the Δ9-THC/cannabidiol (CBD) ratio [
[6]
].Chandra S, Radwan MM, Chandrani, Majumdar G, Church JC, Tom, et al. New trends in cannabis potency in USA and Europe during the last decade (2008-2017)2019;269:5–15. https://doi.org/10.1007/s00406-019-00983-5.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Medical use of cannabis and cannabinoids containing products – regulations in Europe and North America.Eur J Intern Med. 2018; 49: 2-6
- Cannabis use among US adults with anxiety from 2008 to 2017: the role of state-level cannabis legalization.Drug Alcohol Depend. 2020; 214108163
- Medical marijuana laws and adolescent use of marijuana and other substances: alcohol, cigarettes, prescription drugs, and other illicit drugs.Drug Alcohol Depend. 2018; 183: 62-68
- Marijuana use by middle-aged and older adults in the United States, 2015–2016.Drug Alcohol Depend. 2018; 191: 374-381
- Medical cannabis for older patients—treatment protocol and initial results.J Clin Med. 2019; 8: 1819
Chandra S, Radwan MM, Chandrani, Majumdar G, Church JC, Tom, et al. New trends in cannabis potency in USA and Europe during the last decade (2008-2017)2019;269:5–15. https://doi.org/10.1007/s00406-019-00983-5.
- Medical cannabis: aligning use to evidence-based medicine approach.Br J Clin Pharmacol. 2018; 84: 2458-2462
- The effects of cannabis among adults with chronic painandan overview of general harms a systematic review.Ann Intern Med. 2017; 167: 319-331
- Higher odds and rising trends in arrhythmia among young cannabis users with comorbid depression.Eur J Intern Med. 2020; (0)
Richards JR, Blohm E, Toles KA, Jarman AF, Ely DF, Elder JW. The association of cannabis use and cardiac dysrhythmias: a systematic review. Clin Toxicol2020:1–9. https://doi.org/10.1080/15563650.2020.1743847.
- Depression and risk of sudden cardiac death and arrhythmias: a meta-analysis.Psychosom Med. 2017; 79: 153-161
- Autonomy of autonomic dysfunction in major depression.Psychosom Med. 2009; 71: 852-860
- Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure.Am J Cardiol. 2018; 122: 129-134
- Frequency of cardiac rhythm abnormalities in a half million adults.Circ Arrhythmia Electrophysiol. 2018; 11
- Marijuana use in patients with cardiovascular disease.J Am Coll Cardiol. 2020; 75: 320-332
Article info
Publication history
Published online: August 06, 2020
Accepted:
August 4,
2020
Received:
August 3,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
